Mathilde Wagner1,2, Huaibin Mabel Ko3, Manjil Chatterji4, Cecilia Besa1,4, Joana Torres4, Xiaofei Zhang3, Hinaben Panchal5, Stefanie Hectors1, Judy Cho5, Jean-Frederic Colombel5, Noam Harpaz3, Bachir Taouli1,4. 1. Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 2. Sorbonne Universités, UPMC, Department of Radiology, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France. 3. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 4. Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 5. Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract
BACKGROUND AND AIMS: Recently, smooth muscle hypertrophy has been suggested to be a contributor to small bowel lesions secondary to Crohn's disease [CD], in addition to inflammation and fibrosis. Here, we assess the value of magnetic resonance imaging [MRI] for the characterisation of histopathological tissue composition of small bowel CD, including inflammation, fibrosis, and smooth muscle hypertrophy. METHODS: A total of 35 consecutive patients [male/female 17/18, mean age 33 years] with ileal CD, who underwent small bowel resection and a preoperative contrast-enhanced MRI examination within 1 month before surgery, were retrospectively included. Image assessment included qualitative [pattern/degree of enhancement, presence of ulcerations/fistulas/abscesses] and quantitative parameters [wall thickness on T2/T1-weighted images [WI], enhancement ratios, apparent diffusion coefficient [ADC], Clermont and Magnetic Resonance Index of Activity [MaRIA] scores). MRI parameters were compared with histopathological findings including active inflammation, collagen deposition, and muscle hypertrophy using chi square/Fisher or Mann-Whitney tests and univariate/multivariate logistic/linear regression analyses. RESULTS: Forty ileal segments were analysed in 35 patients. Layered pattern at early-post-contrast phase was more prevalent (odds ratio [OR] = 8; p = 0.008), ADC was significantly lower [OR = 0.005; p = 0.022], and MaRIA score was significantly higher [OR = 1.125; p = 0.022] in inflammation grades 2-3 compared with grade 1. Wall thickness on T2WI was significantly increased [OR = 1.688; p = 0.043], and fistulas [OR = 14.5; p = 0.017] were more prevalent in segments with disproportionately increased muscle hypertrophy versus those with disproportionately increased fibrosis. MaRIA/Clermont scores, wall thickness on T1WI and T2WI, and ADC were all significantly correlated with degree of muscular hypertrophy. CONCLUSIONS: MRI predicts the degree of inflammation, and can distinguish prominent muscle hypertrophy from prominent fibrosis in ileal CD with reasonable accuracy (area under receiver operating characteristic curve [AUROC] > 0.7).
BACKGROUND AND AIMS: Recently, smooth muscle hypertrophy has been suggested to be a contributor to small bowel lesions secondary to Crohn's disease [CD], in addition to inflammation and fibrosis. Here, we assess the value of magnetic resonance imaging [MRI] for the characterisation of histopathological tissue composition of small bowel CD, including inflammation, fibrosis, and smooth muscle hypertrophy. METHODS: A total of 35 consecutive patients [male/female 17/18, mean age 33 years] with ileal CD, who underwent small bowel resection and a preoperative contrast-enhanced MRI examination within 1 month before surgery, were retrospectively included. Image assessment included qualitative [pattern/degree of enhancement, presence of ulcerations/fistulas/abscesses] and quantitative parameters [wall thickness on T2/T1-weighted images [WI], enhancement ratios, apparent diffusion coefficient [ADC], Clermont and Magnetic Resonance Index of Activity [MaRIA] scores). MRI parameters were compared with histopathological findings including active inflammation, collagen deposition, and muscle hypertrophy using chi square/Fisher or Mann-Whitney tests and univariate/multivariate logistic/linear regression analyses. RESULTS: Forty ileal segments were analysed in 35 patients. Layered pattern at early-post-contrast phase was more prevalent (odds ratio [OR] = 8; p = 0.008), ADC was significantly lower [OR = 0.005; p = 0.022], and MaRIA score was significantly higher [OR = 1.125; p = 0.022] in inflammation grades 2-3 compared with grade 1. Wall thickness on T2WI was significantly increased [OR = 1.688; p = 0.043], and fistulas [OR = 14.5; p = 0.017] were more prevalent in segments with disproportionately increased muscle hypertrophy versus those with disproportionately increased fibrosis. MaRIA/Clermont scores, wall thickness on T1WI and T2WI, and ADC were all significantly correlated with degree of muscular hypertrophy. CONCLUSIONS: MRI predicts the degree of inflammation, and can distinguish prominent muscle hypertrophy from prominent fibrosis in ileal CD with reasonable accuracy (area under receiver operating characteristic curve [AUROC] > 0.7).
Authors: Onofrio A Catalano; Michael S Gee; Emanuele Nicolai; Francesco Selvaggi; Gianluca Pellino; Alberto Cuocolo; Angelo Luongo; Marco Catalano; Bruce R Rosen; Debra Gervais; Mark G Vangel; Andrea Soricelli; Marco Salvatore Journal: Radiology Date: 2015-10-05 Impact factor: 11.105
Authors: F Rieder; D Bettenworth; C Ma; C E Parker; L A Williamson; S A Nelson; G van Assche; A Di Sabatino; Y Bouhnik; R W Stidham; A Dignass; G Rogler; S A Taylor; J Stoker; J Rimola; M E Baker; J G Fletcher; J Panes; W J Sandborn; B G Feagan; V Jairath Journal: Aliment Pharmacol Ther Date: 2018-06-19 Impact factor: 8.171
Authors: Ilyssa O Gordon; Dominik Bettenworth; Arne Bokemeyer; Amitabh Srivastava; Christophe Rosty; Gert de Hertogh; Marie E Robert; Mark A Valasek; Ren Mao; Satya Kurada; Noam Harpaz; Paula Borralho; Reetesh K Pai; Rish K Pai; Robert Odze; Roger Feakins; Claire E Parker; Tran Nguyen; Vipul Jairath; Mark E Baker; David H Bruining; J G Fletcher; Brian G Feagan; Florian Rieder Journal: Gastroenterology Date: 2019-08-30 Impact factor: 22.682
Authors: Yael Haberman; Phillip Minar; Rebekah Karns; Phillip J Dexheimer; Sudhir Ghandikota; Samuel Tegge; Daniel Shapiro; Brianne Shuler; Suresh Venkateswaran; Tzipi Braun; Allison Ta; Thomas D Walters; Robert N Baldassano; Joshua D Noe; Joel Rosh; James Markowitz; Jennifer L Dotson; David R Mack; Richard Kellermayer; Anne M Griffiths; Melvin B Heyman; Susan S Baker; Dedrick Moulton; Ashish S Patel; Ajay S Gulati; Steven J Steiner; Neal LeLeiko; Anthony Otley; Maria Oliva-Hemker; David Ziring; Ranjana Gokhale; Sandra Kim; Stephen L Guthery; Stanley A Cohen; Scott Snapper; Bruce J Aronow; Michael Stephens; Greg Gibson; Jonathan R Dillman; Marla Dubinsky; Jeffrey S Hyams; Subra Kugathasan; Anil G Jegga; Lee A Denson Journal: J Crohns Colitis Date: 2020-08-08 Impact factor: 9.071
Authors: Ilyssa O Gordon; Dominik Bettenworth; Arne Bokemeyer; Amitabh Srivastava; Christophe Rosty; Gert de Hertogh; Marie E Robert; Mark A Valasek; Ren Mao; Jiannan Li; Noam Harpaz; Paula Borralho; Reetesh K Pai; Robert Odze; Roger Feakins; Claire E Parker; Leonardo Guizzetti; Tran Nguyen; Lisa M Shackelton; William J Sandborn; Vipul Jairath; Mark Baker; David Bruining; Joel G Fletcher; Brian G Feagan; Rish K Pai; Florian Rieder Journal: Gut Date: 2021-05-05 Impact factor: 23.059
Authors: Jie Wang; Sinan Lin; Jonathan Mark Brown; David van Wagoner; Claudio Fiocchi; Florian Rieder Journal: Immunol Rev Date: 2021-05-16 Impact factor: 10.983